vTv Therapeutics Inc. Quarterly Interest Expense in USD from Q1 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
vTv Therapeutics Inc. quarterly/annual Interest Expense history and growth rate from Q1 2016 to Q4 2023.
  • vTv Therapeutics Inc. Interest Expense for the quarter ending December 31, 2023 was $7K, a 16.7% increase year-over-year.
  • vTv Therapeutics Inc. Interest Expense for the twelve months ending December 31, 2023 was $13K, a 13.3% decline year-over-year.
  • vTv Therapeutics Inc. annual Interest Expense for 2023 was $13K, a 13.3% decline from 2022.
  • vTv Therapeutics Inc. annual Interest Expense for 2022 was $15K, a 25% increase from 2021.
  • vTv Therapeutics Inc. annual Interest Expense for 2021 was $12K, a 98.3% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $13K $7K +$1K +16.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $12K $4K -$4K -50% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $16K $2K +$2K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $14K $0 -$1K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $15K $6K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $8K +$2K +33.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $1K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $6K -$229K -97.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0 -$222K -100% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q4 2020 $692K $67K -$216K -76.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $908K $235K -$169K -41.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $1.08M $222K -$292K -56.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $1.37M $168K -$458K -73.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $1.83M $283K -$460K -61.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-29
Q3 2019 $2.29M $404K -$418K -50.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $2.71M $514K -$356K -40.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 $3.06M $626K -$229K -26.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $3.29M $743K -$109K -12.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $3.4M $822K -$27K -3.18% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $3.43M $870K +$38K +4.57% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $3.39M $855K +$296K +53% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $3.09M $852K Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $849K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $832K +$831K +83100% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $559K +$557K +27850% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q2 2016 $1K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $2K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.